Major Japanese Photo Firm Plans Toyama Buy To Enter Drug Market
This article was originally published in PharmAsia News
Executive Summary
Fujifilm Holdings plans to acquire Toyama Chemical to make the Japanese pharmaceutical company its first major venture into the drug industry. Fujifilm sees the acquisition worth $9.2 billion in annual sales in 10 years, triple current Fujifilm sales. Fujifilm's president said his company plans other mergers and acquisitions in the medical business to replace the photography business, which has been changed by digital cameras. The Toyama takeover is the latest of a string of 20 takeovers under company president Shigetaka Komori. (Click here for more - a subscription may be required